These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16529959)

  • 1. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-bound factor Xa regulates tissue factor activity.
    Hathcock J; Rusinova E; Vaananen H; Nemerson Y
    Biochemistry; 2007 May; 46(20):6134-40. PubMed ID: 17469850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS; Mackman N; Fan ST; Ruf W
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow dependence of factor X activation by tissue factor-factor VIIa.
    Contino PB; Andree HA; Nemerson Y
    J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
    Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
    Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide.
    Le DT; Rapaport SI; Rao LV
    Thromb Haemost; 1994 Dec; 72(6):848-55. PubMed ID: 7740453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex.
    Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
    FEBS J; 2006 Jan; 273(2):374-87. PubMed ID: 16403024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor.
    Persson E
    Thromb Res; 2008; 123(1):171-6. PubMed ID: 18550154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.